Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Collegium Pharmaceutical Inc

COLL
Current price
36.64 USD -0.77 USD (-2.06%)
Last closed 37.56 USD
ISIN US19459J1043
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 1 348 469 632 USD
Yield for 12 month +56.38 %
1Y
3Y
5Y
10Y
15Y
COLL
21.11.2021 - 28.11.2021

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts. Address: 100 Technology Center Drive, Stoughton, MA, United States, 02072

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

43.25 USD

P/E ratio

15.7368

Dividend Yield

Current Year

+566 767 000 USD

Last Year

+463 933 000 USD

Current Quarter

+145 276 000 USD

Last Quarter

+144 923 000 USD

Current Year

+326 169 000 USD

Last Year

+209 488 000 USD

Current Quarter

+90 806 000 USD

Last Quarter

+91 456 000 USD

Key Figures COLL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 347 360 000 USD
Operating Margin TTM 32.68 %
PE Ratio 15.7368
Return On Assets TTM 11.24 %
PEG Ratio
Return On Equity TTM 47.87 %
Wall Street Target Price 43.25 USD
Revenue TTM 576 652 992 USD
Book Value 6.7 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 7.2 %
Dividend Yield
Gross Profit TTM 345 743 000 USD
Earnings per share 2.66 USD
Diluted Eps TTM 2.66 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 52.3 %
Profit Margin 17.32 %

Dividend Analytics COLL

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History COLL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation COLL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 15.7368
Forward PE 6.2461
Enterprise Value Revenue 2.8376
Price Sales TTM 2.3384
Enterprise Value EBITDA 4.5745
Price Book MRQ 6.2261

Financials COLL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators COLL

For 52 weeks

20.95 USD 42.29 USD
50 Day MA 37.17 USD
Shares Short Prior Month 6 286 618
200 Day MA 35.02 USD
Short Ratio 21.77
Shares Short 6 351 017
Short Percent 24.45 %